| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.49 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.5 | 0.004 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.45 | 0.008 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.43 | 0.008 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.32 | 0.009 |